Literature DB >> 23882434

Aripiprazole withdrawal: a case report.

Randy A Sansone1, Robert J Sawyer.   

Abstract

Entities:  

Year:  2013        PMID： 23882434      PMCID： PMC3719459     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN： 2158-8333


× No keyword cloud information.
  22 in total

1.  Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal.

Authors:  P M Llorca; G Vaiva; C Lancon
Journal:  Can J Psychiatry       Date:  2001-02       Impact factor: 4.356

2.  [Chorea following withdrawal of quetiapine].

Authors:  P E Jiménez-Caballero; J M Velázquez-Pérez; C Marsal-Alonso; A Alvarez-Tejerina
Journal:  Rev Neurol       Date:  2004 Jun 1-15       Impact factor: 0.870

3.  Reversible withdrawal dyskinesia associated with quetiapine.

Authors:  Costas Michaelides; Manisha Thakore-James; Raymon Durso
Journal:  Mov Disord       Date:  2005-06       Impact factor: 10.338

4.  Quetiapine discontinuation syndrome.

Authors:  Deborah R Kim; Jeffrey P Staab
Journal:  Am J Psychiatry       Date:  2005-05       Impact factor: 18.112

5.  Treatment of withdrawal dyskinesia.

Authors:  Vivian Kafantaris; Judith Hirsch; Ema Saito; Natasha Bennett
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2005-11       Impact factor: 8.829

6.  Sudden akathisia after a ziprasidone dose reduction.

Authors:  E Timucin Oral; Kursat Altinbas; Simden Demirkiran
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

7.  Reversible hyperkinetic movement disorder associated with quetiapine withdrawal.

Authors:  Mohammed T Ahmad; Kumar M Prakash
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

8.  Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. The Collaborative Crossover Study Group.

Authors:  G D Tollefson; M A Dellva; C A Mattler; J M Kane; D A Wirshing; B J Kinon
Journal:  J Clin Psychopharmacol       Date:  1999-10       Impact factor: 3.153

9.  Withdrawal-emergent rabbit syndrome during dose reduction of risperidone.

Authors:  K Nishimura; M Tsuka; N Horikawa
Journal:  Eur Neuropsychopharmacol       Date:  2001-08       Impact factor: 4.600

10.  Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.

Authors:  J F Rosenbaum; M Fava; S L Hoog; R C Ascroft; W B Krebs
Journal:  Biol Psychiatry       Date:  1998-07-15       Impact factor: 13.382
View more
  2 in total

1.  The relationship between dopamine receptor blockade and cognitive performance in schizophrenia: a [11C]-raclopride PET study with aripiprazole.

Authors:  Sangho Shin; Seoyoung Kim; Seongho Seo; Jae Sung Lee; Oliver D Howes; Euitae Kim; Jun Soo Kwon
Journal:  Transl Psychiatry       Date:  2018-04-24       Impact factor: 6.222

2.  Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation-Is It Feasible to Develop Evidence-Based Guidelines?

Authors:  Graham Blackman; Ebenezer Oloyede; Mark Horowitz; Robert Harland; David Taylor; James MacCabe; Philip McGuire
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 9.306
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.